Abstract
Purpose
Nonperfusion of retinal tissue due to arterial occlusion leads inevitably to mostly irreversible retinal damage. Until today no evidence-based treatment exists. Inhalation of 100% oxygen at high atmospheric pressure causes an increased solubility of oxygen in the blood that helps the retinal tissue to survive through diffusion in case of an artery occlusion till vascular recanalization occurs. Hence the purpose of this study is to compare the visual outcome in patients with retinal branch artery obstruction treated with hyperbaric oxygen versus patients treated with hemodilution only.
Methods
Non-randomized, monocentric, retrospective study. Patients with diagnosis of non-arteritic retinal branch artery occlusion (BRAO) treated with hyperbaric oxygen therapy between 1997 and 2017. Exclusion criteria were central retinal artery occlusion, presence of a cilioretinal artery and arteritic cases. The control group was matched based on visual acuity (VA) at admission, age, and delay between symptoms and beginning of clinical care.
Results
The control group and the matching oxygen group contained 14 patients each. Initial VA in the matched HBO group was 0.18 ± 0.19 and 0.23 ± 0.19 in the control group (p = 0.57). Final VA at discharge was 0.69 ± 0.29 in the matched oxygen group and 0.32 ± 0.23 in the control group (p = 0.0009). HBO-treated patients had a significant visual increase compared with the control group. The most common comorbidities were arterial hypertension and vascular sclerosis.
Conclusion
HBO treatment appears to have a beneficial effect on visual outcome in patients with retinal branch artery occlusion. HBO treatment could be a rescue therapy at an early stage of BRAO, especially to bridge the time of a potential reperfusion. However, further, prospective, randomized clinical trials are required to verify this assumption.
Similar content being viewed by others
References
Cringle SJ, Yu PK, Su EN, Yu DY (2006) Oxygen distribution and consumption in the developing rat retina. Invest Ophthalmol Vis Sci 47(9):4072–4076. https://doi.org/10.1167/iovs.05-1638
Butler FK Jr, Hagan C, Murphy-Lavoie H (2008) Hyperbaric oxygen therapy and the eye. Undersea Hyperb Med 35(5):333–387
Dattilo M, Newman NJ, Biousse V (2018) Acute retinal arterial ischemia. Ann Eye Sci 3. doi:https://doi.org/10.21037/aes.2018.05.04
Feltgen N, Pielen A (2017) Retinal artery occlusion. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 114(2):177–190. https://doi.org/10.1007/s00347-016-0432-4
Nipken LH, Schmidt D (1996) Incidence, localization, length and course of the cilioretinal artery. Is there an effect on the course of temporal rental arteries? Klin Monatsbl Augenheilkd 208(4):229–234. https://doi.org/10.1055/s-2008-1035201
Hayreh SS (2018) Central retinal artery occlusion. Indian J Ophthalmol 66(12):1684–1694. https://doi.org/10.4103/ijo.IJO_1446_18
Hayreh SS, Zimmerman MB (2005) Central retinal artery occlusion: visual outcome. Am J Ophthalmol 140(3):376–391. https://doi.org/10.1016/j.ajo.2005.03.038
Mason JO 3rd, Shah AA, Vail RS, Nixon PA, Ready EL, Kimble JA (2008) Branch retinal artery occlusion: visual prognosis. Am J Ophthalmol 146(3):455–457. https://doi.org/10.1016/j.ajo.2008.05.009
Rumelt S, Brown GC (2003) Update on treatment of retinal arterial occlusions. Curr Opin Ophthalmol 14(3):139–141
Rumelt S, Dorenboim Y, Rehany U (1999) Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 128(6):733–738
Online A (2016) Retinale arterielle Verschlüsse. https://www.awmf.org/uploads/tx_szleitlinien/045-013l_S2e_Retinale_Arterienverschluesse_2017-08.pdf
Feist RM, Emond TL (2005) Translumenal Nd:YAG laser embolysis for central retinal artery occlusion. Retina 25(6):797–799
Garcia-Arumi J, Martinez-Castillo V, Boixadera A, Fonollosa A, Corcostegui B (2006) Surgical embolus removal in retinal artery occlusion. Br J Ophthalmol 90(10):1252–1255. https://doi.org/10.1136/bjo.2006.097642
Mueller AJ, Neubauer AS, Schaller U, Kampik A, European Assessment Group for Lysis in the E (2003) Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol 121(10):1377–1381. https://doi.org/10.1001/archopht.121.10.1377
Schumacher M, Schmidt D, Jurklies B, Gall C, Wanke I, Schmoor C, Maier-Lenz H, Solymosi L, Brueckmann H, Neubauer AS, Wolf A, Feltgen N, Group EA-S (2010) Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 117(7):1367–1375 e1361. https://doi.org/10.1016/j.ophtha.2010.03.061
Schultheiss M, Hartig F, Spitzer MS, Feltgen N, Spitzer B, Husing J, Rupp A, Ziemann U, Bartz-Schmidt KU, Poli S (2018) Intravenous thrombolysis in acute central retinal artery occlusion-a prospective interventional case series. PLoS One 13(5):e0198114. https://doi.org/10.1371/journal.pone.0198114
Piantadosi CA (1999) Physiology of hyperbaric hyperoxia. Respir Care Clin N Am 5(1):7–19 v
Carlisle R, Lanphier EH, Rahn H (1964) Hyperbaric oxygen and persistence of vision in retinal ischemia. J Appl Physiol 19:914–918. https://doi.org/10.1152/jappl.1964.19.5.914
Jampol LM (1987) Oxygen therapy and intraocular oxygenation. Trans Am Ophthalmol Soc 85:407–437
Landers MB 3rd (1978) Retinal oxygenation via the choroidal circulation. Trans Am Ophthalmol Soc 76:528–556
Menzel-Severing J, Siekmann U, Weinberger A, Roessler G, Walter P, Mazinani B (2012) Early hyperbaric oxygen treatment for nonarteritic central retinal artery obstruction. Am J Ophthalmol 153(3):454–459 e452. https://doi.org/10.1016/j.ajo.2011.08.009
Weinberger AW, Siekmann UP, Wolf S, Rossaint R, Kirchhof B, Schrage NF (2002) Treatment of acute central retinal artery occlusion (CRAO) by hyperbaric oxygenation therapy (HBO)—pilot study with 21 patients. Klin Monatsbl Augenheilkd 219(10):728–734. https://doi.org/10.1055/s-2002-35687
Aisenbrey S, Krott R, Heller R, Krauss D, Rossler G, Heimann K (2000) Hyperbaric oxygen therapy in retinal artery occlusion. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 97(7):461–467
Beiran I, Goldenberg I, Adir Y, Tamir A, Shupak A, Miller B (2001) Early hyperbaric oxygen therapy for retinal artery occlusion. Eur J Ophthalmol 11(4):345–350
Weiss JN (2010) Hyperbaric oxygen treatment of retinal artery occlusion. Undersea Hyperb Med 37(3):167–172
Weiss JN (2009) Hyperbaric oxygen treatment of nonacute central retinal artery occlusion. Undersea Hyperb Med 36(6):401–405
Marx RE (1983) A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg 41(6):351–357
Aachen HZE (2018)
Hayreh SS, Zimmerman MB, Kimura A, Sanon A (2004) Central retinal artery occlusion. Retinal survival time. Exp Eye Res 78(3):723–736
David NJ, Norton EW, Gass JD, Beauchamp J (1967) Fluorescein angiography in central retinal artery occlusion. Arch Ophthalmol 77(5):619–629
Li HK, Dejean BJ, Tang RA (1996) Reversal of visual loss with hyperbaric oxygen treatment in a patient with Susac syndrome. Ophthalmology 103(12):2091–2098
Gaydar V, Ezrachi D, Dratviman-Storobinsky O, Hofstetter S, Avraham-Lubin BC, Goldenberg-Cohen N (2011) Reduction of apoptosis in ischemic retinas of two mouse models using hyperbaric oxygen treatment. Invest Ophthalmol Vis Sci 52(10):7514–7522. https://doi.org/10.1167/iovs.11-7574
Soares A, Gomes NL, Mendonca L, Ferreira C (2017) The efficacy of hyperbaric oxygen therapy in the treatment of central retinal artery occlusion. BMJ Case Rep 2017. doi:https://doi.org/10.1136/bcr-2017-220113
Bagli BS, Cevik SG, Cevik MT (2018) Effect of hyperbaric oxygen treatment in central retinal artery occlusion. Undersea Hyperb Med 45(4):421–425
Matsuo T (2001) Multiple occlusive retinal arteritis in both eyes of a patient with rheumatoid arthritis. Jpn J Ophthalmol 45(6):662–664
Fisher M (1997) Characterizing the target of acute stroke therapy. Stroke 28(4):866–872
Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, Feng L, Meyer BC, Olson S, Schwamm LH, Yoo AJ, Marshall RS, Meyers PM, Yavagal DR, Wintermark M, Guzy J, Starkman S, Saver JL, Investigators MR (2013) A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 368(10):914–923. https://doi.org/10.1056/NEJMoa1212793
Astrup J, Siesjo BK, Symon L (1981) Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 12(6):723–725
McLeod D (2016) Ischemic penumbra in retina endures: vascular neuropathology is reconciled. Neural Regen Res 11(5):737–739. https://doi.org/10.4103/1673-5374.181367
McLeod D, Beatty S (2015) Evidence for an enduring ischaemic penumbra following central retinal artery occlusion, with implications for fibrinolytic therapy. Prog Retin Eye Res 49:82–119. https://doi.org/10.1016/j.preteyeres.2015.06.001
Hayreh SS (2014) Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res 41:1–25. https://doi.org/10.1016/j.preteyeres.2014.04.001
Baron JC, von Kummer R, del Zoppo GJ (1995) Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. Stroke 26(12):2219–2221
McLeod D (2012) Letter to the editor: partial central retinal artery occlusion offers a unique insight into the ischemic penumbra. Clin Ophthalmol 6:9–22. https://doi.org/10.2147/OPTH.S28232
Hayreh SS, Podhajsky PA, Zimmerman MB (2009) Branch retinal artery occlusion: natural history of visual outcome. Ophthalmology 116 (6):1188-1194 e1181-1184. doi:https://doi.org/10.1016/j.ophtha.2009.01.015
Stone R, Zink H, Klingele T, Burde RM (1977) Visual recovery after central retinal artery occlusion: two cases. Ann Ophthalmol 9(4):445–450
Perkins SA, Magargal LE, Augsburger JJ, Sanborn GE (1987) The idling retina: reversible visual loss in central retinal artery obstruction. Ann Ophthalmol 19(1):3–6
Gallasch G (1984) Results and suggested indications for hemodilution in arterial and venous vascular occlusions of the retina. Fortschr Ophthalmol 81(4):349–352
Wolf S, Hoberg A, Bertram B, Jung F, Kiesewetter H, Reim M (1989) Video fluorescein angiography follow-up of patients with retinal artery occlusion. Klin Monatsbl Augenheilkd 195(3):154–160. https://doi.org/10.1055/s-2008-1046428
Kieswetter H, Korber N, Jung F, Reim M (1983) Rheologic findings in patients with acute central retinal artery occlusion. Graefes Arch Clin Exp Ophthalmol 220(2):92–95
Fraser SG, Adams W (2009) Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev 1:CD001989. https://doi.org/10.1002/14651858.CD001989.pub2
AWMF (2015) Sekundärprophylaxe ischämischer Schlaganfall und transitorische ischämische Attacke
Chen CS, Lee AW, Campbell B, Lee T, Paine M, Fraser C, Grigg J, Markus R (2011) Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke 42(8):2229–2234. https://doi.org/10.1161/STROKEAHA.111.613653
Hattenbach LO, Kuhli-Hattenbach C, Scharrer I, Baatz H (2008) Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol 146(5):700–706. https://doi.org/10.1016/j.ajo.2008.06.016
Chang YS, Jan RL, Weng SF, Wang JJ, Chio CC, Wei FT, Chu CC (2012) Retinal artery occlusion and the 3-year risk of stroke in Taiwan: a nationwide population-based study. Am J Ophthalmol 154(4):645–652 e641. https://doi.org/10.1016/j.ajo.2012.03.046
Callizo J, Feltgen N, Pantenburg S, Wolf A, Neubauer AS, Jurklies B, Wachter R, Schmoor C, Schumacher M, Junker B, Pielen A, European Assessment Group for Lysis in the E (2015) Cardiovascular risk factors in central retinal artery occlusion: results of a prospective and standardized medical examination. Ophthalmology 122(9):1881–1888. https://doi.org/10.1016/j.ophtha.2015.05.044
Leisser C, Kaufmann TA, Feltgen N, Schumacher M, Schmoor C, Meckel S (2015) Distribution of internal carotid artery plaque locations among patients with central retinal artery occlusion in the Eagle study population. Graefes Arch Clin Exp Ophthalmol 253(8):1227–1230. https://doi.org/10.1007/s00417-014-2804-2
Rudkin AK, Lee AW, Chen CS (2010) Vascular risk factors for central retinal artery occlusion. Eye (Lond) 24(4):678–681. https://doi.org/10.1038/eye.2009.142
Schmidt D, Schumacher M, Feltgen N (2009) Circadian incidence of non-inflammatory retinal artery occlusions. Graefes Arch Clin Exp Ophthalmol 247(4):491–494. https://doi.org/10.1007/s00417-008-0989-y
Opremcak E, Rehmar AJ, Ridenour CD, Borkowski LM, Kelley JK (2008) Restoration of retinal blood flow via translumenal Nd:YAG embolysis/embolectomy (TYL/E) for central and branch retinal artery occlusion. Retina 28(2):226–235. https://doi.org/10.1097/IAE.0b013e31814b1d6e
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Human and animal right and informed consent
This article does not contain any studies with animals performed by any of the authors. Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Schmidt, I., Walter, P., Siekmann, U. et al. Development of visual acuity under hyperbaric oxygen treatment (HBO) in non arteritic retinal branch artery occlusion. Graefes Arch Clin Exp Ophthalmol 258, 303–310 (2020). https://doi.org/10.1007/s00417-019-04568-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-019-04568-9